Predictive factors for invasive intraductal papillary mucinous neoplasm of the pancreas

다국어 초록 (Multilingual Abstract)

Backgrounds/Aims: Intraductal papillary mucinous neoplasm (IPMN) of the pancreas has malignant potential. Predicting invasive IPMN has proven difficult and controversial. We tried to identify predictive factors for invasive IPMN. Methods: Thirty six patients underwent resection for IPMN from February 2001 to July 2011. Clinicopathological features including demographic, imaging, microscopic, and serological findings were retrospectively reviewed. Receiver operating characteristic (ROC) curve analysis was used to analyze sensitivity and specificity of all possible cut-off values for the diameter of the main pancreatic duct and mass size predicting invasive IPMN. Student t-test, chi-square test, and logistic regression were used for univariate and multivariate analysis. Results: The mean age was 63.5±8.4 years. Males were more commonly affected (58.3% vs 41.7%). Pancreaticoduodenectomy was performed in 55.6% of patients, distal pancreatectomy in 36.1%, and central pancreatic resection in 8.3%. Non-invasive IPMNs were present in 80.6% (n=29), whereas invasive IPMNs were present in 19.4% (n=7). In univariate analysis, tumor location (p=0.036), Kuroda classification (p=0.048), mural nodule (p=0.016), and main duct dilatation (≥8 mm) (p=0.006) were statistically significant variables. ROC curve analysis showed that a value of 8 mm for the main duct dilatation and a value of 35 mm for the size of the mass lesion have 80% sensitivity and 75% specificity and 100% sensitivity and 82.6% specificity, respectively. However, in multivariate analysis, main ductal dilatation (≥8 mm) was identified to be the only independent factor for invasive IPMN (p=0.049). Conclusions: Main duct dilatation appears to be a useful indicator for predicting invasive IPMN. (Korean J Hepatobiliary Pancreat Surg 2011;15:237-242)

목차 (Table of Contents)

• INTRODUCTION
• METHODS
• RESULTS
• DISCUSSION
• REFERENCES

참고문헌 (Reference)

• 1 이상목, "췌관내 유두상 점액성 종양(IPMT)의 외과적 치료" 한국간담췌외과학회 11 (11): 36-41, 2007
• 2 Kloppel G, "World Health Organization International Histological Classification of Tumours: Histological Typing of Tumors of the Exocrine Pancreas. 2nd ed" Berlin; Springer-Verlag 1996
• 3 Bosman FT,Carneiro F, "WHO Classification of Tumours of the Digestive System: Tumours of the Pancreas. 4th ed" Berlin; Springer 2010
• 4 Lee CJ, "Risk of malignancy in resected cystic tumors of the pancreas < or =3 cm in size: is it safe to observe asymptomatic patients? A multi-institutional report" 12 : 234-242, 2008
• 5 Wilentz RE, "Pathology of cancer of the pancreas" 7 : 43-65, 1998
• 6 Jang JY, "Multicenter analysis of clinicopathologic features of intraductal papillary mucinous tumor of the pancreas: is it possible to predict the malignancy before surgery" 12 : 124-132, 2005
• 7 Kobayashi G, "Mode of progression of intraductal papillary-mucinous tumor of the pancreas: analysis of patients with follow-up by EUS" 40 : 744-751, 2005
• 8 Vullierme MP, "Malignant intraductal papillary mucinous neoplasm of the pancreas: in situ versus invasive carcinoma surgical resectability" 245 : 483-490, 2007
• 9 Yamaguchi T, "Long-term follow-up of intraductal papillary mucinous neoplasm of the pancreas with ultrasonography" 3 : 1136-1143, 2005
• 10 Yamada Y, "Invasive carcinomas derived from intraductal papillary mucinous neoplasms of the pancreas: a long-term follow-up assessment with CT imaging" 30 : 885-890, 2006
• 11 Chiu SS, "Intraductal papillary mucinous tumour of the pancreas: differentiation of malignancy and benignancy by CT" 61 : 776-783, 2006
• 12 Taouli B, "Intraductal papillary mucinous tumors of the pancreas: features with multimodality imaging" 26 : 223-231, 2002
• 13 Schmidt CM, "Intraductal papillary mucinous neoplasms: predictors of malignant and invasive pathology" 246 : 644-651, 2007
• 14 Sohn TA, "Intraductal papillary mucinous neoplasms of the pancreas: an updated experience" 239 : 788-797, 2004
• 15 Bassi C, "Intraductal papillary mucinous neoplasms (IPMNs): is it time to (sometimes) spare the knife" 57 : 287-289, 2008
• 16 Ogawa H, "Intraductal papillary mucinous neoplasm of the pancreas: assessment of the likelihood of invasiveness with multisection CT" 248 : 876-886, 2008
• 17 Sahani DV, "Intraductal papillary mucinous neoplasm of pancreas: multi-detector row CT with 2D curved reformations--correlation with MRCP" 238 : 560-569, 2006
• 18 Tanaka M, "International Association of Pancreatology. International consensus guidelines for management of intraductal papillary mucinous neoplasms and mucinous cystic neoplasms of the pancreas" 6 : 17-32, 2006
• 19 Cho KR, "Genetic alterations in the adenoma--carcinoma sequence" 70 (70): 1727-1731, 1992
• 20 Pelaez-Luna M, "Do consensus indications for resection in branch duct intraductal papillary mucinous neoplasm predict malignancy? A study of 147 patients" 102 : 1759-1764, 2007
• 21 Baba T, "Distinguishing benign0 from malignant intraductal papillary mucinous tumors of the pancreas by imaging techniques" 29 : 212-217, 2004
• 22 Klimstra DS, "Cystic, mucin-producing neoplasms of the pancreas: the distinguishing features of mucinous cystic neoplasms and intraductal papillary mucinous neoplasms" 22 : 318-329, 2005